Myeloma Philadelphia HealthTree Round Table - Audience Q&A with Faculty

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Recent Advances in Multiple Myeloma with Dr. Dan Vogl
▶︎

Recent Advances in Multiple Myeloma with Dr. Dan Vogl

More Options, More Hope: The New Reality for Newly Diagnosed Myeloma | Gurbakhash Kaur, MD #myeloma
▶︎

More Options, More Hope: The New Reality for Newly Diagnosed Myeloma | Gurbakhash Kaur, MD #myeloma

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions
▶︎

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions

Unexplained Hip Pain - Theresa | Multiple Myeloma | The Patient Story
▶︎

Unexplained Hip Pain - Theresa | Multiple Myeloma | The Patient Story

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
▶︎

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

FAQs: Immunotherapy for Multiple Myeloma: Exploring Options Through Your Disease Journey
▶︎

FAQs: Immunotherapy for Multiple Myeloma: Exploring Options Through Your Disease Journey

What is a surrogate end point? #myeloma
▶︎

What is a surrogate end point? #myeloma

What are the barriers to research in the community oncology setting?
▶︎

What are the barriers to research in the community oncology setting?

Ivermectin to Treat Cancer? Get the FACTS
▶︎

Ivermectin to Treat Cancer? Get the FACTS

Erin's Multiple Myeloma Story: From Back Pain to a Stage 3 Diagnosis | The Patient Story
▶︎

Erin's Multiple Myeloma Story: From Back Pain to a Stage 3 Diagnosis | The Patient Story

Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor
▶︎

Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor

Melinda Bachini survived cholangiocarcinoma | bile duct cancer | bilirubin | hemngioma | cisplatin
▶︎

Melinda Bachini survived cholangiocarcinoma | bile duct cancer | bilirubin | hemngioma | cisplatin

Learning how to learn | Barbara Oakley | TEDxOaklandUniversity
▶︎

Learning how to learn | Barbara Oakley | TEDxOaklandUniversity

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
▶︎

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Relapsed Multiple Myeloma: What Every Patient Needs to Know
▶︎

Relapsed Multiple Myeloma: What Every Patient Needs to Know

Ciltacabtagene Autoleucel (CARVYKTI) - a BCMA-Directed  CAR T-Cell Therapy for Multiple Myeloma
▶︎

Ciltacabtagene Autoleucel (CARVYKTI) - a BCMA-Directed CAR T-Cell Therapy for Multiple Myeloma

037 From Patient to Author: Jonathan Gluck’s Myeloma Story
▶︎

037 From Patient to Author: Jonathan Gluck’s Myeloma Story

EBRI-Milken Institute Retirement Symposium — Defaults and Glidepaths in the Age of Longevity
▶︎

EBRI-Milken Institute Retirement Symposium — Defaults and Glidepaths in the Age of Longevity